Massively inspiring. When I said the actual cost to provide healthcare is 10-20% of what we pay in the US, people thought I was nuts. Seems I was wrong—it’s even less.
@_TamaraWinterhttps://twitter.com/DoubleEph/status/1113068382763483137 …
-
-
https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/highlights.pdf … Here is the breakdown. From this it seems like the comp and insurance to physicians could be a huge cost, but the whole system seems to be bloated. So you are completely right. I somehow remembered that R&D expense is much more significant.
-
Even if the RnD in the US is only 3% of spending, the profits from the US spending can still effectively subsidise research that companies do outside of the US, no? It seems more relevant to look at how much profit companies make in US market and how many % of that goes to RnD
End of conversation
New conversation -
-
-
Yes, don’t think that is true. UK, Germany, Denmark, France, Japan, Switzerland all have massive pharma r and d. I can believe that US consumers have been a disproportionately valuable cash cow though.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.